semaglutide injection site Where to Inject Semaglutide? Tips and Sites for Injecting
Description
Apr 2, 2026 Americans pay more for GLP-1 medications than almost anyone else on earth
Retatrutide (LY3437943) is Eli Lillys experimental triple-agonist drug that activates: GLP-1 (Glucagon-like peptide-1) reduces appetite and slows digestion GIP (Glucose-dependent insulinotropic peptide) enhances insulin sensitivity Glucagon receptor increases fat metabolism and energy expenditure In phase-2 trials, Retatrutide achieved up to 24% body-weight reduction rivaling or even surpassing bariatric surgery outcomes
Slower Digestion Food stays in the stomach longer, helping you feel full for extended periods
Low blood sugar (hypoglycemia), particularly for those also taking other medications for diabetes
It is not approved by the FDA and is not intended for human or veterinary use, clinical applications, diagnostic procedures, or therapeutic treatment
